Citation from the publications of

Adler LA; Resnick S; Kunz M; Devinsky O
"Open-label trial of venlafaxine in adults with attention deficit disorder"
Psychopharmacology bulletin 1995 ; 31(4):785-788
Antidepressants or stimulants are commonly used to treat attention deficit disorder (ADD). We report the results of an open-label trial of the recently marketed antidepressant venlafaxine in 16 adult patients with ADD. Patients were treated with venlafaxine (25 to 225 mg/day) for 8 weeks. Four patients discontinued treatment within the first week because of sedation, agitation, or nausea. In the remaining 12 patients, venlafaxine treatment decreased ADD ratings by almost half

Check for full text:  

# 12816 (MEDL:8851654)


This publication list a product of the NYU Faculty Bibliography.